Rebecca Robbins
Posts
Sanofi Plans to Cut the Price of Insulin
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
Novo Nordisk Says It Will Slash the Price of Insulin
The company’s decision follows a similar move by its rival, Eli Lilly, this month.
A Drug Company Exploited a Safety Requirement to Make Money
With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition.
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
F.D.A. Allows Pharmacists to Prescribe Pfizer’s Covid Treatment Pills
Previously, only doctors, nurses or physician assistants were allowed to prescribe the treatment, known as Paxlovid.
W.T.O. Agrees to Limited Relaxing of Patent Protections on Covid Vaccines
The agreement is a limited measure that is likely to have little impact on global vaccine supply.
Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefit and serious safety risks.
35 companies sign on to produce generic versions of Pfizer’s Covid pill.
The New York Times - Business: This post first appeared in The New York Times - Business. Read the original article.
Biogen's Aduhelm Sales Total $2 Million in Second Quarter
The drug from Biogen, called Aduhelm, is expected to generate billions in sales. It could also strain Medicare’s budget within a few years.
Pfizer will turn to a plant in Africa to help supply the continent with vaccines next year.
The deal, which only involves the final stages of manufacturing, falls short of the technology transfer that public health activists have called for.